No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological / pharmacology
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Biomarkers, Tumor / immunology
-
Biomarkers, Tumor / metabolism
-
Breast / cytology
-
Breast / pathology
-
CD8-Positive T-Lymphocytes / immunology*
-
CD8-Positive T-Lymphocytes / metabolism
-
CD8-Positive T-Lymphocytes / transplantation
-
Carcinoma, Ovarian Epithelial
-
Costimulatory and Inhibitory T-Cell Receptors / antagonists & inhibitors
-
Costimulatory and Inhibitory T-Cell Receptors / immunology
-
Costimulatory and Inhibitory T-Cell Receptors / metabolism
-
Disease-Free Survival
-
Female
-
Humans
-
Immunotherapy / methods*
-
Lymphocytes, Tumor-Infiltrating / immunology*
-
Lymphocytes, Tumor-Infiltrating / metabolism
-
Neoplasms, Glandular and Epithelial / immunology
-
Neoplasms, Glandular and Epithelial / mortality
-
Neoplasms, Glandular and Epithelial / pathology
-
Neoplasms, Glandular and Epithelial / therapy*
-
Ovarian Neoplasms / immunology
-
Ovarian Neoplasms / mortality
-
Ovarian Neoplasms / pathology
-
Ovarian Neoplasms / therapy*
-
Prognosis
Substances
-
Antineoplastic Agents, Immunological
-
Biomarkers, Tumor
-
Costimulatory and Inhibitory T-Cell Receptors